Diagnosis and management of Zollinger-Ellison syndrome

Practical Gastroenterology

Volumn 26, Issue 2, 2002, Pages 15-32

  Wolfe, M Michael ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; CUSHING SYNDROME; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; FAMILY HISTORY; GASTRIN BLOOD LEVEL; GASTRINOMA; GLUCAGONOMA; HYPERPARATHYROIDISM; INSULINOMA; LAPAROTOMY; MORBIDITY; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID HYPERPLASIA; PATHOGENESIS; PATIENT MONITORING; STOMACH ACID SECRETION; SURVIVAL RATE; ZOLLINGER ELLISON SYNDROME;

EID: 0036175272     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Zollinger-Ellison syndrome and other hypersecretory states
2. Thirty years' experience with gastrinoma
3. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas
4. Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome
5. Clinical course of nonsurgically treated Zollinger-Ellison syndrome
6. Zollinger-Ellison syndrome: Clinical presentation, pathology, diagnosis and treatment
7. Diagnosis of Zollinger-Ellison syndrome: From symptoms to biological evidence
8. Diagnosis and treatment of Zollinger-Ellison syndrome
9. Gastrinoma
10. The Zollinger-Ellison syndrome: Reappraisal and evaluation of 260 registered cases
11. Clinical features and advances in biological diagnostic for Zollinger-Ellison syndrome
12. Pancreatic endocrine tumors
13. The gastrinoma triangle: Operative indications
14. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study
15. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy
16. Zollinger-Ellison syndrome: Pathogenesis, diagnosis, and management
17. Trophic effects of gastrin
18. Zollinger-Ellison syndrome: Recognition and management of acid hypersecretion
19. Zollinger-Ellison syndrome: Improved treatment options for this complex disorder
20. Management of Zollinger-Ellison syndrome
21. Review article: The management of Zollinger-Ellison syndrome
22. Zollinger-Ellison syndrome
23. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome
24. Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety
25. Radioimmunoassay of gastrin
26. Prospective study of provocative angiograms to localize functional islet cell tumors of the pancreas
27. Endoscopic ultrasonography in the preoperative localization of pancreatic endocrine tumors
28. Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome
29. Somatostatin receptor scintigraphy in gastrinomas
30. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas
31. Role of acid suppressants in patients with Zollinger-Ellison syndrome
32. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome
33. Use of omeprazole in Zollinger-Ellison syndrome: A prospective nine-year study of efficacy and safety
34. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome
35. Rabeprazole therapy is effective in Zollinger-Ellison syndrome and idiopathic gastric acid hypersecretion
36. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome
37. Prilosec [package insert]
38. Prevacid [package insert]
39. Identification of the characteristics influencing the degree of antisecretory activity of PPIs
40. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects
41. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
42. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
43. Medical and surgical options in the management of patients with gastrinoma
44. Benign and malignant gastrinoma
45. Gastrinoma: New medical and surgical approaches
46. The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome
47. Surgery to cure the Zollinger-Ellison syndrome